# Admin-Core

> **NIH NIH U54** · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · 2021 · $996,702

## Abstract

Project Summary/Abstract 
The COVID-19 pandemic significantly affects the entire State of Arizona but impacts communities along the 
border with Mexico disproportionally. Majority Latinx and American Indian communities along this border have 
higher infection rates and less access to testing and vaccination. This proposed supplement aims to increase 
access to testing and related services for these underserved transnational communities. The expansion of our 
current community-driven and culturally congruent project will advance knowledge about barriers to care and 
effective strategies to increase testing and vaccination in the border region. This application extends the work 
of ASU’s health disparities U54 center grant (RFA-MD-17-005; 5U54MD002316) and its RADx-UP supplement 
(3U54MD002316-14S1) by reducing disparities in COVID-19 diagnostics, vaccination, education, wraparound 
services and health care, with the goal of improving the health of vulnerable and underserved communities. 
The aims of this emergency competitive revision closely match and enhance the aims of the current U54 award 
and its RADx-UP supplement. The focus on populations along the AZ-Mexico border will add to existing 
knowledge about assets and vulnerabilities of diverse transnational communities disproportionally affected by 
the pandemic. The approach empowers local communities, is data driven, and creates the infrastructure 
capacity for community-driven delivery of care. Following a Community Based Participatory Research (CBPR) 
orientation, the revised supplement expands our existing R.A.P.I.D. program by improving access and 
decreasing hesitancy to COVID-19 testing and vaccination among underserved and vulnerable populations in 
the border region. Equality Health Foundation (EHF) will continue to serve as the lead community partner for 
the proposed revised supplement and the ASU Biodesign Clinical Testing Laboratory (ABCTL) will provide and 
analyze the saliva-based polymerase chain reaction (PCR) testing for SARS-CoV-2. Local partners 
coordinated by EHF under the One Community Initiative against COVID-19 will implement the vaccination 
program. Over two years, the revised supplement aims to reach 7,000 additional community members living 
and working along the AZ-Mexico border. CDCC surveys from border communities will be added to the 
ongoing longitudinal study we are conducting to assess the intervention’s impact and also by comparing 
randomly selected participants (N=200) with a matched comparison group (N=200) randomly selected from 
regular testing sites. We will also conduct ongoing COVID-19 variants sequence validation among those tested 
and inform appropriate health authorities if significant variants emerge. The transdisciplinary team has the 
infrastructure, capacity, and community partnerships in place to implement the project effectively and 
efficiently. ASU’s existing NIMHD-funded U54 center, guided by its Community and Scientific Advisory Board...

## Key facts

- **NIH application ID:** 10428154
- **Project number:** 3U54MD002316-15S2
- **Recipient organization:** ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
- **Principal Investigator:** Flavio Francisco Marsiglia
- **Activity code:** U54 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $996,702
- **Award type:** 3
- **Project period:** 2007-09-30 → 2023-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10428154

## Citation

> US National Institutes of Health, RePORTER application 10428154, Admin-Core (3U54MD002316-15S2). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10428154. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*